| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -80 @ USD 105.84 | USD -8,467 | The ETF sold 80 shares of DVA on 2026-01-15. The shares were previously bought for an average price of USD 139.512. The DaVita HealthCare Partners Inc shares were sold for -24.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,694 The average price that the ETF previously sold DVA share for is USD 141.442 which is higher than the selling price of USD 105.84 on 2026-01-15. |
| HSIC - Henry Schein Inc | SELL | -232 @ USD 78.08 | USD -18,115 | The ETF sold 232 shares of HSIC on 2026-01-15. The shares were previously bought for an average price of USD 72.1127. The Henry Schein Inc shares were sold for 8.3% higher than average price of previous purchases. This sale made a profit of USD 1,384 The average price that the ETF previously sold HSIC share for is USD 69.992 so the ETF has sold 232 shares on 2026-01-15 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -112 @ USD 193.74 | USD -21,699 | The ETF sold 112 shares of MOH on 2026-01-15. The shares were previously bought for an average price of USD 239.743. The MOH shares were sold for -19.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,152 The average price that the ETF previously sold MOH share for is USD 262.001 which is higher than the selling price of USD 193.74 on 2026-01-15. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -112 @ USD 193.74 | USD -21,699 | The ETF sold 112 shares of MOH on 2026-01-15. The shares were previously bought for an average price of USD 239.743. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -19.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,152 The average price that the ETF previously sold MOH share for is USD 262.001 which is higher than the selling price of USD 193.74 on 2026-01-15. |
| BAX - Baxter International Inc | SELL | -1,148 @ USD 20.37 | USD -23,385 | The ETF sold 1148 shares of BAX on 2026-01-15. The shares were previously bought for an average price of USD 27.0012. The Baxter International Inc shares were sold for -24.6% lower than average price of previous purchases. This resulted in an overall loss of USD 7,613 The average price that the ETF previously sold BAX share for is USD 30.0992 which is higher than the selling price of USD 20.37 on 2026-01-15. |
| CRL - Creightons Plc | SELL | -108 @ USD 223.47 | USD -24,135 | The ETF sold 108 shares of CRL on 2026-01-15. The shares were previously bought for an average price of USD 172.766. The Creightons Plc shares were sold for 29.3% higher than average price of previous purchases. This sale made a profit of USD 5,476 The average price that the ETF previously sold CRL share for is USD 174.608 so the ETF has sold 108 shares on 2026-01-15 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -348 @ USD 69.96 | USD -24,346 | The ETF sold 348 shares of TECH on 2026-01-15. The shares were previously bought for an average price of USD 62.0253. The Bio-Techne Corp shares were sold for 12.8% higher than average price of previous purchases. This sale made a profit of USD 2,761 The average price that the ETF previously sold TECH share for is USD 64.8347 so the ETF has sold 348 shares on 2026-01-15 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -120 @ USD 204.19 | USD -24,503 | The ETF sold 120 shares of UHS on 2026-01-15. The shares were previously bought for an average price of USD 201.179. The Universal Health Services Inc shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 361 The average price that the ETF previously sold UHS share for is USD 200.639 so the ETF has sold 120 shares on 2026-01-15 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -148 @ USD 171.47 | USD -25,378 | The ETF sold 148 shares of ALGN on 2026-01-15. The shares were previously bought for an average price of USD 170.146. The Align Technology Inc shares were sold for 0.8% higher than average price of previous purchases. This sale made a profit of USD 196 The average price that the ETF previously sold ALGN share for is USD 196.246 which is higher than the selling price of USD 171.47 on 2026-01-15. |
| SOLV - Solventum Corp. | SELL | -324 @ USD 80.44 | USD -26,063 | The ETF sold 324 shares of SOLV on 2026-01-15. The shares were previously bought for an average price of USD 75.3222. The Solventum Corp. shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 1,658 The average price that the ETF previously sold SOLV share for is USD 73.3665 so the ETF has sold 324 shares on 2026-01-15 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -248 @ USD 115.33 | USD -28,602 | The ETF sold 248 shares of RVTY on 2026-01-15. The shares were previously bought for an average price of USD 104.555. The Revvity Inc. shares were sold for 10.3% higher than average price of previous purchases. This sale made a profit of USD 2,672 The average price that the ETF previously sold RVTY share for is USD 105.168 so the ETF has sold 248 shares on 2026-01-15 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -764 @ USD 39.36 | USD -30,071 | The ETF sold 764 shares of MRNA on 2026-01-15. The shares were previously bought for an average price of USD 31.2672. The Moderna Inc shares were sold for 25.9% higher than average price of previous purchases. This sale made a profit of USD 6,183 The average price that the ETF previously sold MRNA share for is USD 36.1135 so the ETF has sold 764 shares on 2026-01-15 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -2,564 @ USD 12.84 | USD -32,922 | The ETF sold 2564 shares of VTRS on 2026-01-15. The shares were previously bought for an average price of USD 10.5129. The Viatris Inc shares were sold for 22.1% higher than average price of previous purchases. This sale made a profit of USD 5,967 The average price that the ETF previously sold VTRS share for is USD 10.9866 so the ETF has sold 2564 shares on 2026-01-15 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -440 @ USD 82.31 | USD -36,216 | The ETF sold 440 shares of COO on 2026-01-15. The shares were previously bought for an average price of USD 81.8429. The The Cooper Companies, Inc. Common Stock shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of USD 206 The average price that the ETF previously sold COO share for is USD 88.0236 which is higher than the selling price of USD 82.31 on 2026-01-15. |
| HOLX - Hologic Inc | SELL | -492 @ USD 75.02 | USD -36,910 | The ETF sold 492 shares of HOLX on 2026-01-15. The shares were previously bought for an average price of USD 69.313. The Hologic Inc shares were sold for 8.2% higher than average price of previous purchases. This sale made a profit of USD 2,808 The average price that the ETF previously sold HOLX share for is USD 70.9874 so the ETF has sold 492 shares on 2026-01-15 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -364 @ USD 105.24 | USD -38,307 | The ETF sold 364 shares of INCY on 2026-01-15. The shares were previously bought for an average price of USD 81.5364. The Incyte Corporation shares were sold for 29.1% higher than average price of previous purchases. This sale made a profit of USD 8,628 The average price that the ETF previously sold INCY share for is USD 77.1503 so the ETF has sold 364 shares on 2026-01-15 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -440 @ USD 88.75 | USD -39,050 | The ETF sold 440 shares of ZBH on 2026-01-15. The shares were previously bought for an average price of USD 100.32. The Zimmer Biomet Holdings Inc shares were sold for -11.5% lower than average price of previous purchases. This resulted in an overall loss of USD 5,091 The average price that the ETF previously sold ZBH share for is USD 102.916 which is higher than the selling price of USD 88.75 on 2026-01-15. |
| PODD - Insulet Corporation | SELL | -156 @ USD 286.49 | USD -44,692 | The ETF sold 156 shares of PODD on 2026-01-15. The shares were previously bought for an average price of USD 291.765. The Insulet Corporation shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 823 The average price that the ETF previously sold PODD share for is USD 280.807 so the ETF has sold 156 shares on 2026-01-15 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -160 @ USD 279.41 | USD -44,706 | The ETF sold 160 shares of WST on 2026-01-15. The shares were previously bought for an average price of USD 263.792. The West Pharmaceutical Services Inc shares were sold for 5.9% higher than average price of previous purchases. This sale made a profit of USD 2,499 The average price that the ETF previously sold WST share for is USD 278.161 so the ETF has sold 160 shares on 2026-01-15 at a higher price than the previous selling average. |
| DGX - Quest Diagnostics Incorporated | SELL | -248 @ USD 190.26 | USD -47,184 | The ETF sold 248 shares of DGX on 2026-01-15. The shares were previously bought for an average price of USD 175.101. The Quest Diagnostics Incorporated shares were sold for 8.7% higher than average price of previous purchases. This sale made a profit of USD 3,759 The average price that the ETF previously sold DGX share for is USD 168.395 so the ETF has sold 248 shares on 2026-01-15 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -1,032 @ USD 47.27 | USD -48,783 | The ETF sold 1032 shares of CNC on 2026-01-15. The shares were previously bought for an average price of USD 49.2357. The Concurrent Technologies Plc shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,029 The average price that the ETF previously sold CNC share for is USD 50.2884 which is higher than the selling price of USD 47.27 on 2026-01-15. |
| LH - Laboratory Corporation of America Holdings | SELL | -184 @ USD 268.89 | USD -49,476 | The ETF sold 184 shares of LH on 2026-01-15. The shares were previously bought for an average price of USD 255.616. The Laboratory Corporation of America Holdings shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of USD 2,442 The average price that the ETF previously sold LH share for is USD 246.24 so the ETF has sold 184 shares on 2026-01-15 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -132 @ USD 394.59 | USD -52,086 | The ETF sold 132 shares of WAT on 2026-01-15. The shares were previously bought for an average price of USD 364.347. The Waters Corporation shares were sold for 8.3% higher than average price of previous purchases. This sale made a profit of USD 3,992 The average price that the ETF previously sold WAT share for is USD 365.441 so the ETF has sold 132 shares on 2026-01-15 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -132 @ USD 394.59 | USD -52,086 | The ETF sold 132 shares of WAT on 2026-01-15. The shares were previously bought for an average price of USD 364.347. The MULETFWATIMETFP shares were sold for 8.3% higher than average price of previous purchases. This sale made a profit of USD 3,992 The average price that the ETF previously sold WAT share for is USD 365.441 so the ETF has sold 132 shares on 2026-01-15 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -324 @ USD 168.57 | USD -54,617 | The ETF sold 324 shares of BIIB on 2026-01-15. The shares were previously bought for an average price of USD 151.207. The Biogen Inc shares were sold for 11.5% higher than average price of previous purchases. This sale made a profit of USD 5,626 The average price that the ETF previously sold BIIB share for is USD 154.246 so the ETF has sold 324 shares on 2026-01-15 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -220 @ USD 268.26 | USD -59,017 | The ETF sold 220 shares of STE on 2026-01-15. The shares were previously bought for an average price of USD 237.987. The STERIS plc shares were sold for 12.7% higher than average price of previous purchases. This sale made a profit of USD 6,660 The average price that the ETF previously sold STE share for is USD 228.77 so the ETF has sold 220 shares on 2026-01-15 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -868 @ USD 69.24 | USD -60,100 | The ETF sold 868 shares of DXCM on 2026-01-15. The shares were previously bought for an average price of USD 72.334. The DexCom Inc shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 2,686 The average price that the ETF previously sold DXCM share for is USD 75.292 which is higher than the selling price of USD 69.24 on 2026-01-15. |
| MTD - Mettler-Toledo International Inc | SELL | -44 @ USD 1496.61 | USD -65,851 | The ETF sold 44 shares of MTD on 2026-01-15. The shares were previously bought for an average price of USD 1310.95. The Mettler-Toledo International Inc shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of USD 8,169 The average price that the ETF previously sold MTD share for is USD 1262.43 so the ETF has sold 44 shares on 2026-01-15 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -44 @ USD 1496.61 | USD -65,851 | The ETF sold 44 shares of MTD on 2026-01-15. The shares were previously bought for an average price of USD 1310.95. The AMUNDI EUR GOV 710 shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of USD 8,169 The average price that the ETF previously sold MTD share for is USD 1262.43 so the ETF has sold 44 shares on 2026-01-15 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -264 @ USD 283.95 | USD -74,963 | The ETF sold 264 shares of HUM on 2026-01-15. The shares were previously bought for an average price of USD 263.914. The Hummingbird Resources PLC shares were sold for 7.6% higher than average price of previous purchases. This sale made a profit of USD 5,290 The average price that the ETF previously sold HUM share for is USD 268.549 so the ETF has sold 264 shares on 2026-01-15 at a higher price than the previous selling average. |
| HUM - Humana Inc | SELL | -264 @ USD 283.95 | USD -74,963 | The ETF sold 264 shares of HUM on 2026-01-15. The shares were previously bought for an average price of USD 263.914. The Humana Inc shares were sold for 7.6% higher than average price of previous purchases. This sale made a profit of USD 5,290 The average price that the ETF previously sold HUM share for is USD 268.549 so the ETF has sold 264 shares on 2026-01-15 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,004 @ USD 82.51 | USD -82,840 | The ETF sold 1004 shares of GEHC on 2026-01-15. The shares were previously bought for an average price of USD 80.621. The GE HealthCare Technologies Inc. shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 1,897 The average price that the ETF previously sold GEHC share for is USD 79.5042 so the ETF has sold 1004 shares on 2026-01-15 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -324 @ USD 260.7 | USD -84,467 | The ETF sold 324 shares of RMD on 2026-01-15. The shares were previously bought for an average price of USD 247.517. The ResMed Inc shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 4,271 The average price that the ETF previously sold RMD share for is USD 247.46 so the ETF has sold 324 shares on 2026-01-15 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -624 @ USD 144.83 | USD -90,374 | The ETF sold 624 shares of A on 2026-01-15. The shares were previously bought for an average price of USD 134.412. The Agilent Technologies Inc shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 6,501 The average price that the ETF previously sold A share for is USD 131.741 so the ETF has sold 624 shares on 2026-01-15 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -376 @ USD 241.28 | USD -90,721 | The ETF sold 376 shares of IQV on 2026-01-15. The shares were previously bought for an average price of USD 199.814. The IQVIA Holdings Inc shares were sold for 20.8% higher than average price of previous purchases. This sale made a profit of USD 15,591 The average price that the ETF previously sold IQV share for is USD 192.047 so the ETF has sold 376 shares on 2026-01-15 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,284 @ USD 84.49 | USD -108,485 | The ETF sold 1284 shares of EW on 2026-01-15. The shares were previously bought for an average price of USD 75.9025. The Edwards Lifesciences Corp shares were sold for 11.3% higher than average price of previous purchases. This sale made a profit of USD 11,026 The average price that the ETF previously sold EW share for is USD 73.6303 so the ETF has sold 1284 shares on 2026-01-15 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -520 @ USD 213.46 | USD -110,999 | The ETF sold 520 shares of CAH on 2026-01-15. The shares were previously bought for an average price of USD 157.544. The Cardinal Health Inc shares were sold for 35.5% higher than average price of previous purchases. This sale made a profit of USD 29,076 The average price that the ETF previously sold CAH share for is USD 144.468 so the ETF has sold 520 shares on 2026-01-15 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -980 @ USD 125.28 | USD -122,774 | The ETF sold 980 shares of ZTS on 2026-01-15. The shares were previously bought for an average price of USD 149.222. The Zoetis Inc shares were sold for -16.0% lower than average price of previous purchases. This resulted in an overall loss of USD 23,463 The average price that the ETF previously sold ZTS share for is USD 162.722 which is higher than the selling price of USD 125.28 on 2026-01-15. |
| IDXX - IDEXX Laboratories Inc | SELL | -176 @ USD 712.12 | USD -125,333 | The ETF sold 176 shares of IDXX on 2026-01-15. The shares were previously bought for an average price of USD 567.613. The IDEXX Laboratories Inc shares were sold for 25.5% higher than average price of previous purchases. This sale made a profit of USD 25,433 The average price that the ETF previously sold IDXX share for is USD 501.8 so the ETF has sold 176 shares on 2026-01-15 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -632 @ USD 208.35 | USD -131,677 | The ETF sold 632 shares of BDX on 2026-01-15. The shares were previously bought for an average price of USD 206.251. The Becton Dickinson and Company shares were sold for 1.0% higher than average price of previous purchases. This sale made a profit of USD 1,327 The average price that the ETF previously sold BDX share for is USD 206.072 so the ETF has sold 632 shares on 2026-01-15 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -428 @ USD 355.35 | USD -152,090 | The ETF sold 428 shares of COR on 2026-01-15. The shares were previously bought for an average price of USD 304.847. The Cencora Inc. shares were sold for 16.6% higher than average price of previous purchases. This sale made a profit of USD 21,615 The average price that the ETF previously sold COR share for is USD 277.623 so the ETF has sold 428 shares on 2026-01-15 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -592 @ USD 277.94 | USD -164,540 | The ETF sold 592 shares of CI on 2026-01-15. The shares were previously bought for an average price of USD 296.8. The Cigna Corp shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 11,165 The average price that the ETF previously sold CI share for is USD 312.014 which is higher than the selling price of USD 277.94 on 2026-01-15. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -224 @ USD 741.92 | USD -166,190 | The ETF sold 224 shares of REGN on 2026-01-15. The shares were previously bought for an average price of USD 678.01. The Regeneron Pharmaceuticals Inc shares were sold for 9.4% higher than average price of previous purchases. This sale made a profit of USD 14,316 The average price that the ETF previously sold REGN share for is USD 689.164 so the ETF has sold 224 shares on 2026-01-15 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -352 @ USD 483.8 | USD -170,298 | The ETF sold 352 shares of HCA on 2026-01-15. The shares were previously bought for an average price of USD 396.914. The HCA Holdings Inc shares were sold for 21.9% higher than average price of previous purchases. This sale made a profit of USD 30,584 The average price that the ETF previously sold HCA share for is USD 379.753 so the ETF has sold 352 shares on 2026-01-15 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -492 @ USD 381.93 | USD -187,910 | The ETF sold 492 shares of ELV on 2026-01-15. The shares were previously bought for an average price of USD 373.171. The Elevance Health Inc shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 4,309 The average price that the ETF previously sold ELV share for is USD 386.129 which is higher than the selling price of USD 381.93 on 2026-01-15. |
| ELV - Elevance Health Inc | SELL | -492 @ USD 381.93 | USD -187,910 | The ETF sold 492 shares of ELV on 2026-01-15. The shares were previously bought for an average price of USD 373.171. The Elevance Health Inc shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 4,309 The average price that the ETF previously sold ELV share for is USD 386.129 which is higher than the selling price of USD 381.93 on 2026-01-15. |
| CVS - CVS Health Corp | SELL | -2,808 @ USD 81.36 | USD -228,459 | The ETF sold 2808 shares of CVS on 2026-01-15. The shares were previously bought for an average price of USD 70.7749. The CVS Health Corp shares were sold for 15.0% higher than average price of previous purchases. This sale made a profit of USD 29,723 The average price that the ETF previously sold CVS share for is USD 63.3838 so the ETF has sold 2808 shares on 2026-01-15 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -272 @ USD 844.13 | USD -229,603 | The ETF sold 272 shares of MCK on 2026-01-15. The shares were previously bought for an average price of USD 721.833. The McKesson Corporation shares were sold for 16.9% higher than average price of previous purchases. This sale made a profit of USD 33,265 The average price that the ETF previously sold MCK share for is USD 675.989 so the ETF has sold 272 shares on 2026-01-15 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -560 @ USD 438.92 | USD -245,795 | The ETF sold 560 shares of VRTX on 2026-01-15. The shares were previously bought for an average price of USD 448.138. The Vertex Pharmaceuticals Inc shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,162 The average price that the ETF previously sold VRTX share for is USD 465.413 which is higher than the selling price of USD 438.92 on 2026-01-15. |
| BMY - Bloomsbury Publishing Plc | SELL | -4,500 @ USD 56.62 | USD -254,790 | The ETF sold 4500 shares of BMY on 2026-01-15. The shares were previously bought for an average price of USD 52.48. The Bloomsbury Publishing Plc shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 18,630 The average price that the ETF previously sold BMY share for is USD 52.9831 so the ETF has sold 4500 shares on 2026-01-15 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -760 @ USD 362.49 | USD -275,492 | The ETF sold 760 shares of SYK on 2026-01-15. The shares were previously bought for an average price of USD 372.037. The Stryker Corporation shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 7,256 The average price that the ETF previously sold SYK share for is USD 378.523 which is higher than the selling price of USD 362.49 on 2026-01-15. |
| MDT - Medtronic PLC | SELL | -2,836 @ USD 99 | USD -280,764 | The ETF sold 2836 shares of MDT on 2026-01-15. The shares were previously bought for an average price of USD 92.5994. The Medtronic PLC shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 18,152 The average price that the ETF previously sold MDT share for is USD 88.762 so the ETF has sold 2836 shares on 2026-01-15 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -3,276 @ USD 90.03 | USD -294,938 | The ETF sold 3276 shares of BSX on 2026-01-15. The shares were previously bought for an average price of USD 98.397. The Boston Scientific Corporation shares were sold for -8.5% lower than average price of previous purchases. This resulted in an overall loss of USD 27,410 The average price that the ETF previously sold BSX share for is USD 95.0832 which is higher than the selling price of USD 90.03 on 2026-01-15. |
| BSX - MULSTRXSSXIMETFP | SELL | -3,276 @ USD 90.03 | USD -294,938 | The ETF sold 3276 shares of BSX on 2026-01-15. The shares were previously bought for an average price of USD 98.397. The MULSTRXSSXIMETFP shares were sold for -8.5% lower than average price of previous purchases. This resulted in an overall loss of USD 27,410 The average price that the ETF previously sold BSX share for is USD 95.0832 which is higher than the selling price of USD 90.03 on 2026-01-15. |
| PFE - Pfizer Inc | SELL | -12,568 @ USD 25.89 | USD -325,386 | The ETF sold 12568 shares of PFE on 2026-01-15. The shares were previously bought for an average price of USD 25.4613. The Pfizer Inc shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 5,388 The average price that the ETF previously sold PFE share for is USD 25.3685 so the ETF has sold 12568 shares on 2026-01-15 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -2,740 @ USD 121.26 | USD -332,252 | The ETF sold 2740 shares of GILD on 2026-01-15. The shares were previously bought for an average price of USD 111.385. The Guild Esports Plc shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of USD 27,058 The average price that the ETF previously sold GILD share for is USD 103.045 so the ETF has sold 2740 shares on 2026-01-15 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,388 @ USD 239.89 | USD -332,967 | The ETF sold 1388 shares of DHR on 2026-01-15. The shares were previously bought for an average price of USD 216.819. The Danaher Corporation shares were sold for 10.6% higher than average price of previous purchases. This sale made a profit of USD 32,023 The average price that the ETF previously sold DHR share for is USD 222.815 so the ETF has sold 1388 shares on 2026-01-15 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,388 @ USD 239.89 | USD -332,967 | The ETF sold 1388 shares of DHR on 2026-01-15. The shares were previously bought for an average price of USD 216.819. The Danaher Corporation shares were sold for 10.6% higher than average price of previous purchases. This sale made a profit of USD 32,023 The average price that the ETF previously sold DHR share for is USD 222.815 so the ETF has sold 1388 shares on 2026-01-15 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,188 @ USD 330.03 | USD -392,076 | The ETF sold 1188 shares of AMGN on 2026-01-15. The shares were previously bought for an average price of USD 306.947. The Amgen Inc shares were sold for 7.5% higher than average price of previous purchases. This sale made a profit of USD 27,423 The average price that the ETF previously sold AMGN share for is USD 298.599 so the ETF has sold 1188 shares on 2026-01-15 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -784 @ USD 541.34 | USD -424,411 | The ETF sold 784 shares of ISRG on 2026-01-15. The shares were previously bought for an average price of USD 529.278. The Intuitive Surgical Inc shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 9,457 The average price that the ETF previously sold ISRG share for is USD 533.754 so the ETF has sold 784 shares on 2026-01-15 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -3,840 @ USD 123.53 | USD -474,355 | The ETF sold 3840 shares of ABT on 2026-01-15. The shares were previously bought for an average price of USD 128.092. The Abbott Laboratories shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of USD 17,518 The average price that the ETF previously sold ABT share for is USD 123.517 so the ETF has sold 3840 shares on 2026-01-15 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -828 @ USD 624.65 | USD -517,210 | The ETF sold 828 shares of TMO on 2026-01-15. The shares were previously bought for an average price of USD 532.216. The Time Out Group plc shares were sold for 17.4% higher than average price of previous purchases. This sale made a profit of USD 76,535 The average price that the ETF previously sold TMO share for is USD 505.113 so the ETF has sold 828 shares on 2026-01-15 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -5,488 @ USD 110.97 | USD -609,003 | The ETF sold 5488 shares of MRK on 2026-01-15. The shares were previously bought for an average price of USD 92.0166. The Marks Electrical Group PLC shares were sold for 20.6% higher than average price of previous purchases. This sale made a profit of USD 104,016 The average price that the ETF previously sold MRK share for is USD 93.7859 so the ETF has sold 5488 shares on 2026-01-15 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -5,488 @ USD 110.97 | USD -609,003 | The ETF sold 5488 shares of MRK on 2026-01-15. The shares were previously bought for an average price of USD 92.0166. The Merck & Company Inc shares were sold for 20.6% higher than average price of previous purchases. This sale made a profit of USD 104,016 The average price that the ETF previously sold MRK share for is USD 93.7859 so the ETF has sold 5488 shares on 2026-01-15 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -2,000 @ USD 338.96 | USD -677,920 | The ETF sold 2000 shares of UNH on 2026-01-15. The shares were previously bought for an average price of USD 416.506. The UnitedHealth Group Incorporated shares were sold for -18.6% lower than average price of previous purchases. This resulted in an overall loss of USD 155,092 The average price that the ETF previously sold UNH share for is USD 465.337 which is higher than the selling price of USD 338.96 on 2026-01-15. |
| ABBV - AbbVie Inc | SELL | -3,900 @ USD 216.75 | USD -845,325 | The ETF sold 3900 shares of ABBV on 2026-01-15. The shares were previously bought for an average price of USD 208.288. The AbbVie Inc shares were sold for 4.1% higher than average price of previous purchases. This sale made a profit of USD 33,002 The average price that the ETF previously sold ABBV share for is USD 194.016 so the ETF has sold 3900 shares on 2026-01-15 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -5,320 @ USD 219.57 | USD -1,168,112 | The ETF sold 5320 shares of JNJ on 2026-01-15. The shares were previously bought for an average price of USD 177.202. The Johnson & Johnson shares were sold for 23.9% higher than average price of previous purchases. This sale made a profit of USD 225,398 The average price that the ETF previously sold JNJ share for is USD 162.752 so the ETF has sold 5320 shares on 2026-01-15 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -1,752 @ USD 1032.97 | USD -1,809,763 | The ETF sold 1752 shares of LLY on 2026-01-15. The shares were previously bought for an average price of USD 881.831. The Eli Lilly and Company shares were sold for 17.1% higher than average price of previous purchases. This sale made a profit of USD 264,796 The average price that the ETF previously sold LLY share for is USD 825.539 so the ETF has sold 1752 shares on 2026-01-15 at a higher price than the previous selling average. |